Insulin, or glucagon-like peptide 1 (GLP-1) receptor agonists inhibited Aβ induced phosphorylation eIF2α, indicating that stimulating insulin signalling may prevent inflammation mediated synaptic loss and memory impairment through inhibiting/downregulating the PKR signalling pathway. This evidence concerns the gene GCG and memory impairment.